NEW YORK (360Dx) ­–Blood analysis systems firm Abaxis today reported flat revenues for the third quarter of fiscal 2016 in preliminary results, due in part to a difficult to compare quarter and currency effects.

The firm, which markets instruments and consumables for the veterinary and medical spaces, expects revenues of $52 to $53 million in the quarter ended Dec. 31, 2016, flat with the comparable quarter last year and below the average Wall Street estimate of $58 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.